SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-010331
Filing Date
2021-05-03
Accepted
2021-05-03 16:05:50
Documents
53
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 450022
2 ex31-1.htm EX-31.1 11544
3 ex31-2.htm EX-31.2 11342
4 ex32-1.htm EX-32.1 7282
5 ex32-2.htm EX-32.2 7253
  Complete submission text file 0001493152-21-010331.txt   2402426

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE ogen-20210331.xml EX-101.INS 290734
7 XBRL SCHEMA FILE ogen-20210331.xsd EX-101.SCH 31351
8 XBRL CALCULATION FILE ogen-20210331_cal.xml EX-101.CAL 36633
9 XBRL DEFINITION FILE ogen-20210331_def.xml EX-101.DEF 105883
10 XBRL LABEL FILE ogen-20210331_lab.xml EX-101.LAB 231183
11 XBRL PRESENTATION FILE ogen-20210331_pre.xml EX-101.PRE 181762
Mailing Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634
Business Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634 8132867900
ORAGENICS INC (Filer) CIK: 0001174940 (see all company filings)

IRS No.: 593410522 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32188 | Film No.: 21883543
SIC: 2834 Pharmaceutical Preparations